2020 Novartis Performance, Capabilities, Goals and Strategies
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
- Latest organizational and management developments
- Acquisitions and divestitures
- Marketing tactics
- Financial results
- Strengths and weaknesses
- Strategic directions
- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-à-vis their major competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.
More Publications
Novartis: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
US$ 1,520.00
October 2010
140 pages
2020 Kite Pharma Performance, Capabilities, Goals and Strategies
US$ 950.00
January 2020
-
2020 Novo Nordisk Performance, Capabilities, Goals and Strategies
US$ 950.00
January 2020
-
2020 Shire Performance, Capabilities, Goals and Strategies
US$ 950.00
January 2020
-
2020 Vertex Pharmaceuticals Performance, Capabilities, Goals and Strategies
US$ 950.00
January 2020
-
